Jennifer M. Siegel, MD

Adjunct Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Jenny Siegel, MD is an Associate Program Director for the Boston Medical Center Internal Medicine Residency Program where she leads educational efforts around ambulatory clinical training and runs the Urban Health and Health Equities Pathway. She is also Medical Director at the Center for Transgender Medicine and Surgery and an Adjunct Assistant Professor of Medicine at Boston University Chobanian and Avedisian School of Medicine. She received her degree from Harvard Medical School and completed her residency at the University of California, San Francisco through the SFGH Primary Care Track and was a Chief Resident at San Francisco General Hospital. She has special interests in, LGBTQ+ Health, Social and Structural Determinants of Health, Hepatitis C Treatment, Addiction Medicine, and Medical Education. She is board certified in Internal Medicine.

Publications

  • Published 11/1/2024

    Wolfe HL, Hughto JMW, Siegel J, Fix GM, Poteat TC, Streed CG, Hughes LD, Balkan E, Drainoni ML. Exploring Perspectives on HIV Vulnerability Communication among Transgender and Gender Diverse Patients and Primary Care Providers. Arch Sex Behav. 2025 Feb; 54(2):817-826. PMID: 39485606.

    Read at: PubMed

  • Published 12/19/2023

    Crosby B, Gell-Levey IM, Monroe J, Streed CG, Siegel J, Carter EE, Mulkey N, Zumwalt AC. Comparison of faculty and student perceptions of sexual and gender minority content in a preclerkship medical curriculum. BMC Med Educ. 2023 Dec 19; 23(1):973. PMID: 38115000.

    Read at: PubMed

  • Published 12/13/2023

    Wolfe HL, Fix GM, Hughto JMW, Hughes LD, Operario D, Hadland SE, Siegel J, Drainoni ML. Understanding how primary care providers report discussing substance use with transgender and gender diverse patients. Patient Educ Couns. 2024 Mar; 120:108101. PMID: 38103396.

    Read at: PubMed

  • Published 7/24/2023

    Mammadli T, Siegel J, Negi N. Examining Differences in Substance Use Outcomes and Related Correlates among Transfeminine and Transmasculine Adults Using the 2017 New York State Patient Characteristics Survey. Subst Use Misuse. 2023; 58(13):1668-1677. PMID: 37486040.

    Read at: PubMed

  • Published 4/1/2023

    Wolfe HL, Drainoni ML, Klasko-Foster L, Fix GM, Siegel J, Mimiaga MJ, Reisner SL, Hughto JMW. Structural Equation Modeling of Stigma and HIV Prevention Clinical Services Among Transgender and Gender Diverse Adults: The Mediating Role of Substance Use and HIV Sexual Risk. J Acquir Immune Defic Syndr. 2023 Apr 01; 92(4):300-309. PMID: 36515898.

    Read at: PubMed

Education

  • Harvard Medical School, MD
  • Smith College, BA